• Mashup Score: 1
    CAR-T therapy in myeloma and lymphoma - 2 year(s) ago

    CAR-T therapy has revolutionized the treatment landscape of several hematological malignancies, and ongoing clinical trials continue to provide valuable data…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      🚨 We've just posted a new podcast on #CART therapy in #Lymphoma & #MultipleMyeloma! 🎧 Listen to it here: 👉https://t.co/BKRVSW44By 👈 @VJHemOnc #iwCART22 #HemOnc #LYMsm #NonHodgkinLymphoma #DLBCL #FollicularLymphoma #MantleCellLymphoma #MMSM #Myeloma #ImmunoOnc #tcellrx

  • Mashup Score: 1
    The current state of CAR-T therapy in lymphoma - 2 year(s) ago

    Over the last few decades, advances in immunotherapies including CAR-T therapy have revolutionized the treatment of patients with relapsed/refractory (R/R)…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      🚨 NEW podcast alert 🚨 🎧 Hear about the current state of #CART therapy in #Lymphoma with leading experts David Maloney, Caron Jacobson & @LNastoupilMD 👉https://t.co/l36HVhn9HJ👈 @VJHemOnc #iwCART22 #HemOnc #ImmunoOnc #tcellrx #NonHodgkinLymphoma #FollicularLymphoma #LYMsm

  • Mashup Score: 0
    iwCAR-T Sessions: Updates in CAR-T for melanoma and sarcomas Archives | VJOncology - 2 year(s) ago

    Welcome to the iwCAR-T Sessions with the Video Journal of Oncology (VJOncology.com).A roundtable discussion was filmed in Tampa, FL, during the iwCAR-T 2022 workshop with experts Syliva Lee (Fred Hutchinson Cancer Center, Seattle, WA) and John Mulliniax (H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL) and Mihaela Druta (H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL),…

    Source: VJOncology
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJOncology
      VJOncology

      🎥Watch leading experts discuss CAR-T for melanoma & sarcomas in our latest #iwCART22 session 📢In this session Sylvia Lee, John Mulliniax & Mihaela Druta review TIL therapy for melanoma & T-cell therapies for sarcomas! ➡️https://t.co/ztdHfAaExZ #MelSM #skcSMS#scmSM #ImmunoOnc https://t.co/EbHFKbJ1ox

  • Mashup Score: 2
    VJOncology – The video journal of oncology - 2 year(s) ago

    The Video Journal of Oncology (VJOncology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the awareness and understanding of oncology

    Source: VJOncology
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJOncology
      VJOncology

      📢Keep up to date on CAR-T therapies for solid tumors with our #iwCART22 sessions over at https://t.co/ys1d8pDAKO! Check out the latest session on melanoma + sarcomas with Sylvia Lee, John Mulliniax & Mihaela Druta! Watch here:🎥https://t.co/oq7C9tKWHE #MelSM #scmSM #ImmunoOnc https://t.co/AHiRva4iGb

  • Mashup Score: 2
    AML Sessions: AML updates from iwCAR-T 2022 | VJHemOnc - 2 year(s) ago

    John DiPersio:Our session today primarily focused on cellular therapies for acute myelogenous leukemia. And we all acknowledge that there are challenges that need to be overcome using effector cells consisting of either T-cells or other effector cells such as NK cells. So I’m sitting here with Saar Gill, who’s at the University of Pennsylvania and Rizwan Romee who’s at Dana-Farber Cancer…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      #iwCART22 | In this exclusive session, leading experts John DiPersio, Saar Gill & @romeerizwan discuss the challenges of CAR-T therapy in AML, the use of CAR-NK therapy, and more: 🎥: https://t.co/VMXGYIVrUs #AMLsm #LeuSM #HemOnc #CARTcell #ImmunoOnc #tcellrx https://t.co/MymPOaDMq0

  • Mashup Score: 1
    ALL Sessions: ALL updates from iwCAR-T 2022 | VJHemOnc - 2 year(s) ago

    Noelle Frey:Hi, my name’s Noelle Frey, and I’m here with Dr. Bijal Shah and Shannon Maude. We are at the Fourth International Working Group for CAR-T Therapy down here in Tampa Bay, Florida. We just finished what I thought was a very enlightening and exciting session about CAR T-cell therapy for adults and pediatrics with B-cell ALL. I don’t know about you guys, but I thought the session was so…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      Join leading experts Noelle Frey, Bijal Shah and Shannon Maude as they discuss the future of CAR-T therapy for ALL and the impact of the approval of tisa-cel in adult patients: 👉https://t.co/JnbLRessYx👈 #iwCART22 #CARTcell #ALLsm #LeuSM #tcellrx #ImmunoOnc #HemOnc https://t.co/z3pej2hsJy

  • Mashup Score: 0
    CLL Sessions: CLL updates from iwCAR-T 2022 | VJHemOnc - 2 year(s) ago

    John Gribben:Hello, I’m John Gribben. We’re at the iwCAR-T meeting in Tampa, Florida, and we’ve just come out of this CLL session, although we’re going to cover some stuff that isn’t CLL related. We had a usual combination of live speakers and virtual speakers, but I’m joined today by my two colleagues who were talking to us live: that’s Saar Gill from University of Pennsylvania, and Mazyar…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      #iwCART22 | Leading experts John Gribben, Mazyar Shadman, and Saar Gill discuss some of the barriers to CAR-T therapy in CLL & debate the optimal use of CAR-T in CLL: 🎥: https://t.co/LP6UyM1HQC #CLLsm #LeuSM #ImmunoOnc #HemOnc #CARTcell #tcellrx https://t.co/jU90OiUXIf

  • Mashup Score: 0
    VJSessions: Patient focused CAR-T updates | VJHemOnc - 2 year(s) ago

    Kedar Kirtane:My name is Kedar Kirtane. I’m an assistant member in the department of head, neck, and endocrine malignancies at Moffitt Cancer Center, and I have with me today, Dr Laura Oswald and Dr Heather Jim, both from the department of health outcomes and behavior, and we just finished our patient-focused session. So Dr Oswald, perhaps you could provide a summary of the talk you just…

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      All #iwCART22 sessions are now live! Listen in as experts @DrKedarKirtane, Laura Oswald, and Heather Jim discuss the importance of studying patient-reported outcomes in CAR-T recipients: 👉https://t.co/J59aFTdarE👈 #CARTcell #HemOnc #ImmunoOnc https://t.co/axydhtYEBN

  • Mashup Score: 0
    VJSessions: iwCAR-T day 2 highlights | VJHemOnc - 2 year(s) ago

    David Maloney:I’m Dr David Maloney from the Fred Hutch Cancer Center in Seattle Washington. I’m joined by my colleagues here from the first day of the lymphoma session, leukemia session at iwCAR-T, Dr Noelle Frey from UPenn and Dr John Gribben from Barts in London. I think we had another really exciting day one. We started it off with, I guess, where CAR-Ts really kind of started off with ALL….

    Source: VJHemOnc
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of VJHemOnc
      VJHemOnc

      #iwCART22 | Join leading experts David Maloney, John Gribben, and Noelle Frey as they share their highlights from this year's meeting, focusing on the lymphoma & leukemia sessions. 🎥: https://t.co/asFuT4tr3r #LymSM #LeuSM #HemOnc #CARTcell https://t.co/ydDvza6J6C

Load More